Hamid Soraya

1.3k total citations
56 papers, 1.0k citations indexed

About

Hamid Soraya is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Hamid Soraya has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 10 papers in Epidemiology. Recurrent topics in Hamid Soraya's work include Metabolism, Diabetes, and Cancer (10 papers), Cardiac Ischemia and Reperfusion (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Hamid Soraya is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Cardiac Ischemia and Reperfusion (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Hamid Soraya collaborates with scholars based in Iran, United States and Canada. Hamid Soraya's co-authors include Alireza Garjani, Nasrin Maleki‐Dizaji, Maryam Rameshrad, Arash Khorrami, Mahmoud Ghazi‐Khansari, Jafar Rezaie, Afagh Garjani, Yadollah Shakiba, Fatemeh Fathiazad and Sanaz Hamedeyazdan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Hamid Soraya

51 papers receiving 994 citations

Peers

Hamid Soraya

CCM

EPIDE

EDM

Yueh-Min Lin Taiwan

Galina Chipitsyna United States

Yu‐Lan Yeh Taiwan

Chia-Yao Shen Taiwan

Liang Yang China

Neha Rani India

Xiaoyu Liu China

Dan Qu China

Jin Chen China

Gergő Szűcs Hungary

Yueh-Min Lin Taiwan

Hamid Soraya

649 ×1.2

184 ×1.0

137 ×1.0

CCM

144 ×1.0

EPIDE

109 ×0.9

EDM

Citations per year, relative to Hamid Soraya Hamid Soraya (= 1×) peers Yueh-Min Lin

Countries citing papers authored by Hamid Soraya

Since Specialization

Citations

This map shows the geographic impact of Hamid Soraya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Soraya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Soraya more than expected).

Fields of papers citing papers by Hamid Soraya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Soraya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Soraya. The network helps show where Hamid Soraya may publish in the future.

Co-authorship network of co-authors of Hamid Soraya

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Soraya. A scholar is included among the top collaborators of Hamid Soraya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Soraya. Hamid Soraya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jun, Hamid Soraya, Jimin Xu, et al.. (2025). Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge. Antiviral Research. 238. 106155–106155. 2 indexed citations

Soraya, Hamid, et al.. (2025). Neuroprotective effects of ivermectin on Alzheimer’s model induced by streptozotocin in rats. Neurodegenerative Disease Management. 1–9. 1 indexed citations

Soraya, Hamid, et al.. (2025). MPO and its role in cancer, cardiovascular and neurological disorders: An update. Biochemical and Biophysical Research Communications. 755. 151578–151578. 2 indexed citations

Soraya, Hamid, et al.. (2025). Ivermectin’s neuroprotective effects decrease with prolonged use after cerebral ischemia/reperfusion. Metabolic Brain Disease. 40(6). 234–234.

Soraya, Hamid, et al.. (2024). Aerobic interval training preconditioning protocols inhibit isoproterenol-induced pathological cardiac remodeling in rats: Implications on oxidative balance, autophagy, and apoptosis. Sports Medicine and Health Science. 6(4). 344–357.

Soraya, Hamid, et al.. (2024). INVESTIGATING THE MEDICATION HISTORY OF PATIENTS WITH STROKE ADMITTED TO URMIA IMAM KHOMEINI HOSPITAL. 34(12). 816–825.

Shafiei‐Irannejad, Vahid, et al.. (2024). Cardioprotective Effect of Hydroalcoholic Extract of Lepidium draba on Isoproterenol-Induced Acute Myocardial Infarction in Rats. Journal of Reports in Pharmaceutical Sciences. 12(1). 1 indexed citations

Laher, Ismail, et al.. (2023). Neuroprotective effects of ivermectin against transient cerebral ischemia-reperfusion in rats. Metabolic Brain Disease. 38(8). 2807–2815. 6 indexed citations

Malekinejad, Hassan, et al.. (2022). Pre‐treatment or post‐treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. Fundamental and Clinical Pharmacology. 37(3). 589–598. 5 indexed citations

10.

Abbaszadeh, Samin, et al.. (2022). Effects of pre-treatment with metoprolol and diltiazem on cerebral ischemia/reperfusion-induced injuries. Brazilian Journal of Pharmaceutical Sciences. 58. 3 indexed citations

11.

Vaez, Haleh, Hamid Soraya, Alireza Garjani, & Tooba Gholikhani. (2021). Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease. Advanced Pharmaceutical Bulletin. 13(1). 36–47. 12 indexed citations

12.

Soraya, Hamid. (2020). Prophylactic Use of Chloroquine May Impair Innate Immune System Response against SARS-Cov-2. Pharmaceutical Sciences. 26(Covid-19). S78–S79. 2 indexed citations

13.

Abbaszadeh, Samin, et al.. (2020). Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies. European Journal of Pharmacology. 882. 173277–173277. 15 indexed citations

14.

Abbaszadeh, Samin, et al.. (2019). Hydroalcoholic Extract from Rhizomes of Cynodon dactylon Improve Hemodynamic and Electrocardiogram Parameters in Myocardial Infarction in Rats. Pharmaceutical Sciences. 25(3). 198–204. 1 indexed citations

15.

Shojaei‐Zarghani, Sara, Samin Abbaszadeh, Mohammad Alizadeh, et al.. (2018). The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. Advanced Pharmaceutical Bulletin. 8(1). 97–105. 7 indexed citations

16.

Rameshrad, Maryam, Nasrin Maleki‐Dizaji, Haleh Vaez, et al.. (2015). Lipopolysaccharide Induced Activation of Toll Like Receptor 4 in Isolated Rat Heart Suggests a Local Immune Response in Myocardium.. PubMed. 12(2). 104–16. 22 indexed citations

17.

Soraya, Hamid, Milad Moloudizargari, Shahin Aghajanshakeri, et al.. (2015). Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat. DARU Journal of Pharmaceutical Sciences. 23(1). 10–10. 18 indexed citations

18.

Soraya, Hamid, Maryam Rameshrad, Aram Mokarizadeh, & Alireza Garjani. (2015). Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat. Bioimpacts. 5(1). 3–8. 34 indexed citations

19.

Soraya, Hamid, Alexander S. Clanachan, Maryam Rameshrad, et al.. (2014). Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. European Journal of Pharmacology. 737. 77–84. 53 indexed citations

20.

Soraya, Hamid, et al.. (2012). Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacological Reports. 64(6). 1476–1484. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact